Depressive Disorders Market Revenue, Trends, Growth Factors, Region and Country Analysis & Forecast To 2035 Read More: https://www.rootsanalysis.com/reports/depressive-disorders-pipeline-review-developer-landscape-and-competitive-insights/252.html Depression is a chronic medical condition characterized by a persistent feeling of sadness and lack of interest in external stimuli. It is a commonly diagnosed mental health disorder and is considered among the leading causes of disability across the globe. It has been estimated that over 300 million people (considering all age groups) suffer from depression worldwide.

Portable X Ray Devices Market Size, Revenue Share, Drivers & Trends Analysis, 2035 The portable x ray devices market is estimated to be worth $900 million in 2021 and is expected to grow at CAGR of 13% during the forecast period. Read More: https://www.rootsanalysis.com/reports/handheld-x-ray-imaging-devices-market.html Since the discovery of X-rays, the field of medical imaging has evolved significantly, offering a non-invasive means for physicians to accurately visualize almost all major organ systems for diagnostic purposes.

Avastin Biosimilars Market Overview Avastin® (bevacizumab) is VEGF-A targeting, humanized monoclonal antibody-based therapeutic developed by Genentech and Roche. Read More: https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html It was the first angiogenesis inhibitor drug to be approved by the US FDA. Avastin® was first approved for treatment of advanced colon cancer (2004); since then, the drug has been approved for advanced lung cancers (2006), metastatic breast cancers (2008), kidney cancers and brain (glioblastoma) cancers (2009). Presently, it is considered an important standard of care in oncology.

Squamous Non-Small Cell Lung Cancer Market Revenue, SWOT, PEST Analysis, Growth Factors, 2035 The “Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Squamous Non-Small Cell Lung Cancer. Read More: https://www.rootsanalysis.com/reports/squamous-non-small-cell-lung-cancer-market.html This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s mechanism of action, dosage and administration, and pharmacological studies, regulatory milestones, and other development activities.

Prenatal Testing and Newborn Screening Market Revenue, Company Profile, Key Trend Analysis & Forecast, 2035 The global non-invasive prenatal testing and newborn screening market is likely be worth $8.2 billion by 2027, representing a CAGR of 15%. Read More: https://www.rootsanalysis.com/reports/global-non-invasive-prenatal-testing-and-newborn-screening-market-2017/167.html It has been estimated that close to 131 million babies are born each year across the globe. Of these, approximately 7.9 million are born with birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising.Genetic testing solutions that enable early detection of genetic abnormalities in fetuses and newborns are important to ensure that the person does not face complications later in life. With the emergence of innovative diagnostic and screening techniques, several methods of genetic testing have become popular. These include carrier testing, preimplantation genetic diagnosis / screening (PGD / PGS), prenatal testing, paternity testing and newborn screening. Amongst these, prenatal testing (primarily Non-invasive prenatal testing (NIPT)) and newborn screening have gained relatively more traction in prenatal and neonatal care.

Healthcare Digital Marketing Market, Revenue Share, Key Growth Trends, Major Players, and Forecast, 2035 The healthcare digital marketing market is estimated to be worth $305 million in 2020 and is expected to grow at CAGR of 26% during the forecast period. Read More: https://www.rootsanalysis.com/reports/healthcare-digital-marketing/323.html Advent of smartphones coupled to the easy accessibility of information on the internet, has rendered it crucial for companies to establish a digital presence. As opposed to traditional strategies, digital marketing is not only cost effective but offers several ancillary benefits, such as targeted outreach and data driven output. In fact, a recent study stated that digital advertising is expected to account for around 50% of the overall global advertisement spend by 2021.

Handheld Ultrasound Scanners Market Size, Revenue Analysis, PEST, Region & Country Forecast, 2035 The handheld ultrasound scanners market is estimated to be worth $404 million in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 11% during the forecast period. Read More: https://www.rootsanalysis.com/reports/handheld-imaging-devices/319.html Since the discovery of ultrasound, the field of medical imaging has evolved significantly, offering non-invasive means for physicians to accurately visualize almost all major organ systems for diagnostic purposes.

KRAS Market Overview The NRAS, HRAS and KRAS market is estimated to be worth $73 million in 2021 and is expected to grow at CAGR of 53.6% during the forecast period. Read More: https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html Close to 10 million fatalities reported in 2020 were observed to be associated with cancer, which is believed to be one of the leading causes of death, globally.

Recent innovation & upcoming trends Drug Repurposing Market to 2035 The drug repurposing market is estimated to be worth $313 million in 2020 and is expected to grow at CAGR of 14.7% during the forecast period. Read More: https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html A prominent concern reported by innovators is attrition (close to 90%) of candidate drugs / therapies owing to various reasons, in addition to therapeutic efficacy and safety. Moreover, it is estimated that a new drug takes anywhere between 10-12 years to progress from the bench to market.

Women’s Digital Health Market Size Analysis, Industry Outlook, & Region Forecast, 2024-2035 Digital health is a broad concept that encompasses telemedicine, teleconsultation, remote monitoring, connected devices, digital health platforms and health applications. Read More: https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html The outbreak of COVID-19 pandemic has propelled the usage of digital technologies in order to receive healthcare, remotely. The revolutionary developments in digital health have transformed medicine and biomedical science as well as promoted early disease diagnosis and treatment. In addition, several FemTech startups are focused on the development of products or offering services to women of all age groups dealing with issues related to pregnancy, periods and menopause.